MIA Reports

A mom describes her son's descent into the harms of psychiatry—and his way out. "It was really difficult to watch Matt decline. He had given up hope that he could get well."

On the Mad in America podcast we talk with Lisa Cosgrove and Brian Piper about their BMJ paper entitled "Undisclosed Financial Conflicts of Interest in the DSM-5 TR: Cross-Sectional Analysis"

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

Philosopher Justin Garson discusses the potential benefit of looking at madness not as disease or defect, but as a designed feature.

Psychiatry’s depression outcomes are poor because its bio-chemical-electrical treatments are based on a depression model that science has flushed down the toilet.

This is what social media does, she says. It draws people in. It hurts people. In the worst cases, it kills people.

After decades of study, billions of dollars spent, and thousands of studies conducted, the failure to identify any genes for schizophrenia should definitively put to rest the notion that schizophrenia is a genetic disorder, according to E. Fuller Torrey.

Justin Karter interviews narrative and philosophical psychologist Mark Freeman about his vision for the future of psychology.

Revealing concerns about BetterHelp’s ability to provide quality, secure treatment—and the unresolved tensions in the science of psychotherapy that services like BetterHelp exploit.

The STAR*D Study has been cited as real-world evidence of the efficacy of antidepressants. In truth, it told of a failed paradigm of care.

In Part 2 of our reader Q&A podcast, MIA founder Robert Whitaker answers questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.

On the Mad in America podcast this week we have Robert Whitaker with us to answer questions sent in by readers and listeners.

In their letter to the editor, Rush et al. have doubled-down on the fraud they committed in their 2006 summary report of STAR*D outcomes.

In this interview, Audrey Clare Farley reveals how our understanding of schizophrenia was built to avoid acknowledging sexual trauma, religious abuse, and racism.

This is a call that challenges how psychiatry is practiced today and ultimately challenges its power in society.

Brooke Siem discusses her experiences of being medicated with antidepressants as a teenager, her withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects.

By embracing the widely popular technology-worship “religion,” psychiatry is permitted to ignore the reality that its repeated failures are evidence that its fundamental paradigm is misguided.

MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.

In this interview with MIA's Justin Karter, psychiatrist Bradley Lewis discusses the value of art, the humanities, and mad studies in shaping a richer understanding of psychological experiences.

On the Mad in America podcast, we hear about the potential of lucid dreaming therapy to aid those struggling with post-traumatic stress.

Supporting a Child, Teen, or Young Person in Crisis - Our guest panel, Ciara Fanlo, Morna Murray and Sami Timimi join host Amy Biancolli to share stories of crisis but also stories of healing and of hope.

We have two guests today. One is Susan Swim, executive director of the Now I See A Person Institute, which she created in 2007...

The American Journal of Psychiatry Needs to Retract Study That Reported Fraudulent Results

Concerns rise about the adverse effects and longer-term harms of GLP-1 injections like Ozempic and Wegovy.

MIA's Justin Karter interviews Micha Frazer-Carroll about her new book, "Mad World: The Politics of Mental Health."